Press Releases Year All Years 2021 2020 2019 2018 2017 2016 2015 2014 Category All Releases Financial Releases Recro Pharma Announces Update on On-Going Phase II Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery Apr 09, 2015 11:00am EDT Recro Pharma Reports Fourth Quarter and Full Year 2014 Financial Results Mar 25, 2015 12:00pm EDT Recro Pharma to Acquire IV/IM Meloxicam and Gainesville, GA GMP Manufacturing Facility and Business Unit From Alkermes Mar 09, 2015 10:00am EDT Recro Pharma Enters Into Common Stock Purchase Agreement With Aspire Capital Feb 03, 2015 1:00pm EST Recro Pharma to Present at the 17th Annual BIO CEO & Investor Conference Feb 02, 2015 9:22pm EST Recro Pharma Reports Third Quarter 2014 Financial Results Nov 10, 2014 12:00pm EST Recro Pharma Announces Dosing of First Patient in Phase II REC-14-013 Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery Oct 29, 2014 8:05pm EDT Recro Pharma to Present at the 2014 Aegis Healthcare & Technology Conference Sep 08, 2014 11:00am EDT Recro Pharma Provides Clinical Strategy Update Following Interim Analysis for Phase IIb Clinical Trial of Dex-IN Sep 04, 2014 8:51pm EDT Recro Pharma Reports Second Quarter 2014 Financial Results Aug 12, 2014 11:00am EDT Prev 1... 8 9 10 11 12 13 14 15 16 17 Next
Recro Pharma Announces Update on On-Going Phase II Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery Apr 09, 2015 11:00am EDT
Recro Pharma to Acquire IV/IM Meloxicam and Gainesville, GA GMP Manufacturing Facility and Business Unit From Alkermes Mar 09, 2015 10:00am EDT
Recro Pharma Announces Dosing of First Patient in Phase II REC-14-013 Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery Oct 29, 2014 8:05pm EDT
Recro Pharma to Present at the 2014 Aegis Healthcare & Technology Conference Sep 08, 2014 11:00am EDT
Recro Pharma Provides Clinical Strategy Update Following Interim Analysis for Phase IIb Clinical Trial of Dex-IN Sep 04, 2014 8:51pm EDT